Synthesis and in vitro cancer cell growth inhibition evaluation of 11-amino-modified 5-Me-indolo[2,3-b]quinolines and their COMPARE analyses
- 25 February 2016
- journal article
- research article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 25 (5) , 879-892
Abstract
No abstract availableKeywords
Funding Information
- the Adaptable and Seamless Technology Transfer Program of JST (AS242Z02199Q)
This publication has 20 references indexed in Scilit:
- Neocryptolepine (Cryprotackieine), A Unique Bioactive Natural Product: Isolation, Synthesis, and Profile of Its Biological ActivityEuropean Journal of Organic Chemistry, 2014
- Development of EGFR-Targeted Nanoemulsion for Imaging and Novel Platinum Therapy of Ovarian CancerPharmaceutical Research, 2014
- Alkaloids as Important Scaffolds in Therapeutic Drugs for the Treatments of Cancer, Tuberculosis, and Smoking CessationCurrent Topics in Medicinal Chemistry, 2013
- JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugsBioorganic & Medicinal Chemistry, 2012
- Synthesis and antitumor activity of cis-dichloridoplatinum(II) complexes of 1,1′-biisoquinolinesEuropean Journal of Medicinal Chemistry, 2010
- Drug–DNA interactions and novel drug designThe Pharmacogenomics Journal, 2002
- Antiplasmodial Activity of Cryptolepis sanguinolenta Alkaloids from Leaves and RootsPlanta Medica, 2000
- Synthesis, and cytotoxic activity of some novel indolo[2,3-b]quinoline derivativesBioorganic & Medicinal Chemistry, 1999
- New alkaloids from Cryptolepis sanguinolentaTetrahedron Letters, 1996
- In VitroBiological Activities of Alkaloids fromCryptolepis sanguinolentaPlanta Medica, 1996